Journal article
KRAS insertion mutations are oncogenic and exhibit distinct functional properties
Nature communications, Vol.7(1), pp.10647-10647
02/08/2016
DOI: 10.1038/ncomms10647
PMCID: PMC4748120
PMID: 26854029
Abstract
Oncogenic KRAS mutations introduce discrete amino acid substitutions that reduce intrinsic Ras GTPase activity and confer resistance to GTPase-activating proteins (GAPs). Here we discover a partial duplication of the switch 2 domain of K-Ras encoding a tandem repeat of amino acids G60_A66dup in a child with an atypical myeloproliferative neoplasm. K-Ras proteins containing this tandem duplication or a similar five amino acid E62_A66dup mutation identified in lung and colon cancers transform the growth of primary myeloid progenitors and of Ba/F3 cells. Recombinant K-Ras(G60_A66dup) and K-Ras(E62_A66dup) proteins display reduced intrinsic GTP hydrolysis rates, accumulate in the GTP-bound conformation and are resistant to GAP-mediated GTP hydrolysis. Remarkably, K-Ras proteins with switch 2 insertions are impaired for PI3 kinase binding and Akt activation, and are hypersensitive to MEK inhibition. These studies illuminate a new class of oncogenic KRAS mutations and reveal unexpected plasticity in oncogenic Ras proteins that has diagnostic and therapeutic implications.
Details
- Title: Subtitle
- KRAS insertion mutations are oncogenic and exhibit distinct functional properties
- Creators
- Yasmine White - Department of Pediatrics, University of California, 1450 3rd St, San Francisco, California 94158, USAAditi Bagchi - Van Andel Institute Graduate School, 333 Bostwick Ave N.E., Grand Rapids, Michigan 49503, USAJessica Van Ziffle - Department of Pathology, University of California, 2340 Sutter St, San Francisco, California 94115, USAAnagha Inguva - Department of Pediatrics, University of California, 1450 3rd St, San Francisco, California 94158, USAGideon Bollag - Plexxikon Inc, 91 Bolivar Dr, Berkeley, California 94710, USAChao Zhang - Plexxikon Inc, 91 Bolivar Dr, Berkeley, California 94710, USAHeidi Carias - Plexxikon Inc, 91 Bolivar Dr, Berkeley, California 94710, USADavid Dickens - Department of Pediatrics, Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation; Helen DeVos Children's Hospital/Spectrum Health Medical Group, 100 Michigan St, Grand Rapids, Michigan 49503, USAMignon Loh - Helen Diller Family Comprehensive Cancer Center, University of California, 1450 3rd St, San Francisco, California 94158, USAKevin Shannon - Helen Diller Family Comprehensive Cancer Center, University of California, 1450 3rd St, San Francisco, California 94158, USAAri J Firestone - Department of Pediatrics, University of California, 1450 3rd St, San Francisco, California 94158, USA
- Resource Type
- Journal article
- Publication Details
- Nature communications, Vol.7(1), pp.10647-10647
- DOI
- 10.1038/ncomms10647
- PMID
- 26854029
- PMCID
- PMC4748120
- NLM abbreviation
- Nat Commun
- ISSN
- 2041-1723
- eISSN
- 2041-1723
- Grant note
- R37CA72614 / NCI NIH HHS Howard Hughes Medical Institute R37 CA072614 / NCI NIH HHS
- Language
- English
- Date published
- 02/08/2016
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984093356902771
Metrics
37 Record Views